Evaluation of Cumulative Meta-analysis of Rare Events as a Tool for Clinical Trials Safety Monitoring.
Siontis GCM., Nikolakopoulou A., Efthimiou O., Räber L., Windecker S., Jüni P.
This meta-analysis evaluates the use of cumulative meta-analysis of rare events as a tool for safety monitoring of clinical trials using the example of coronary bioresorbable vascular scaffold–associated thrombosis.